Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) EPS (Basic) (2020 - 2026)

Journey Medical filings provide 6 years of EPS (Basic) readings, the most recent being -$0.04 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 150.0% to -$0.04 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.47, a 36.49% increase, with the full-year FY2025 number at -$0.47, up 34.72% from a year prior.
  • EPS (Basic) hit -$0.04 in Q4 2025 for Journey Medical, up from -$0.09 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.91 in Q3 2023 to a low of -$1.89 in Q4 2021.
  • Median EPS (Basic) over the past 5 years was -$0.18 (2024), compared with a mean of -$0.37.
  • Biggest five-year swings in EPS (Basic): crashed 36633.33% in 2021 and later soared 259.65% in 2023.
  • Journey Medical's EPS (Basic) stood at -$1.89 in 2021, then skyrocketed by 68.25% to -$0.6 in 2022, then surged by 80.0% to -$0.12 in 2023, then surged by 166.67% to $0.08 in 2024, then crashed by 150.0% to -$0.04 in 2025.
  • The last three reported values for EPS (Basic) were -$0.04 (Q4 2025), -$0.09 (Q3 2025), and -$0.16 (Q2 2025) per Business Quant data.